Polymyalgia rheumatica (patient information): Difference between revisions
No edit summary |
No edit summary |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
Polymyalgia rheumatica (PMR) is an inflammatory disorder involving pain and stiffness in the shoulder and usually also the hip. | Polymyalgia rheumatica (PMR) is an [[inflammatory]] disorder involving [[pain]] and [[stiffness]] in the [[shoulder]] and usually also [[Hip|the hip]]. | ||
==What are the symptoms of Polymyalgia rheumatica?== | ==What are the symptoms of Polymyalgia rheumatica?== | ||
The most typical symptom is pain and stiffness in both shoulders and the neck. This pain usually progresses to the hips, and there | The most typical symptom is pain and stiffness in both shoulders and the [[neck]]. This pain usually progresses to the [[hips]], and there is [[fatigue]] too. It becomes more and more difficult for patients to get around. | ||
Other symptoms include: | Other symptoms include: | ||
* Anemia | * [[Anemia]] | ||
* Appetite loss, which leads to unintentional weight loss | * [[Appetite loss]], which leads to unintentional [[weight loss]] | ||
* Depression | * [[Depression]] | ||
* Fever | * [[Fever]] | ||
There are no specific joint symptoms. | There are no specific [[joint]] symptoms. | ||
Some people with PMR also have giant cell arteritis. This far more serious disease can cause: | Some people with PMR also have [[giant cell arteritis]]. This far more serious disease can cause: | ||
* Heart attack | * [[Heart attack]] | ||
* Stroke | * [[Stroke]] | ||
* Sudden blindness | * [[Blindness|Sudden blindness]] | ||
Gaint cell arteritis presents with : | |||
*[[Headache]] | |||
*[[Jaw pain]] on talking or [[chewing]] | |||
*[[Pain]] or [[weakness]] of arm on movement. | |||
*Trouble in seeing. | |||
==What causes Polymyalgia rheumatica?== | ==What causes Polymyalgia rheumatica?== | ||
The cause is unknown. PMR may occur alone, or with or before giant cell arteritis (also called temporal arteritis), which is inflammation of blood vessels (usually in the head). | The cause is unknown. PMR may occur alone, or with or before [[giant cell arteritis]] (also called [[temporal arteritis]]), which is [[inflammation]] of [[blood vessels]] (usually in the head). | ||
==Who is at highest risk?== | ==Who is at highest risk?== | ||
Line 34: | Line 43: | ||
==Diagnosis== | ==Diagnosis== | ||
Lab tests cannot diagnose polymyalgia rheumatica. However, most patients with this condition have an elevated sedimentation rate (ESR), a blood test that can show certain kinds of inflammation. | Lab tests cannot diagnose polymyalgia rheumatica. However, most patients with this condition have an elevated [[Erythrocyte sedimentation rate|erythrocyte sedimentation rate (ESR)]], a blood test that can show certain kinds of [[inflammation]]. | ||
Other test results for this condition (as well as for giant cell arteritis) include: | Other test results for this condition (as well as for giant cell arteritis) include: | ||
* Abnormal proteins in the blood | * Abnormal [[proteins]] in the [[blood]] | ||
* Abnormal white blood cells | * Abnormal [[white blood cells]] | ||
* Reduced hemoglobin and hematocrit | * Reduced [[hemoglobin]] and [[hematocrit]] | ||
* Signs of anemia | * Signs of [[anemia]] | ||
These tests may also be used to monitor patients' progress. | These tests may also be used to monitor patients' progress. | ||
Line 51: | Line 60: | ||
Although there is no cure for polymyalgia rheumatica, treatment can help prevent patients from becoming disabled. | Although there is no cure for polymyalgia rheumatica, treatment can help prevent patients from becoming disabled. | ||
Low doses of corticosteroids (such as prednisone) can relieve polymyalgia rheumatica within a day or two. The dose can then be slowly reduced to a very low level, but the treatment will need to continue for a long time -- around 2 - 6 years. | Low doses of [[Corticosteroid|corticosteroids]] (such as [[prednisone]]) can relieve polymyalgia rheumatica within a day or two. The dose can then be slowly reduced to a very low level, but the treatment will need to continue for a long time -- around 2 - 6 years. Physical therapy helps in building the strength and reducing the [[stiffness]]. | ||
Corticosteroids cause a variety of side effects that must be carefully monitored and managed. | Corticosteroids cause a variety of side effects that must be carefully monitored and managed. | ||
Line 69: | Line 78: | ||
==Sources== | ==Sources== | ||
http://www.nlm.nih.gov/medlineplus/ency/article/000415.htm | http://www.nlm.nih.gov/medlineplus/ency/article/000415.htm | ||
{{WH}} | |||
{{WS}} | |||
[[Category: | [[Category:Disease]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Rheumatology patient information]] | [[Category:Rheumatology patient information]] | ||
Line 77: | Line 88: | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Dermatology patient information]] | [[Category:Dermatology patient information]] | ||
Latest revision as of 15:00, 13 May 2018
Polymyalgia rheumatica |
Polymyalgia rheumatica On the Web |
---|
Risk calculators and risk factors for Polymyalgia rheumatica |
Editors-in-Chief: C. Michael Gibson, M.S., M.D.; Associate Editor-In-Chief: Ujjwal Rastogi, MBBS [1]
For the WikiDoc page for this topic, click here
Overview
Polymyalgia rheumatica (PMR) is an inflammatory disorder involving pain and stiffness in the shoulder and usually also the hip.
What are the symptoms of Polymyalgia rheumatica?
The most typical symptom is pain and stiffness in both shoulders and the neck. This pain usually progresses to the hips, and there is fatigue too. It becomes more and more difficult for patients to get around.
Other symptoms include:
- Anemia
- Appetite loss, which leads to unintentional weight loss
- Depression
- Fever
There are no specific joint symptoms.
Some people with PMR also have giant cell arteritis. This far more serious disease can cause:
Gaint cell arteritis presents with :
- Trouble in seeing.
What causes Polymyalgia rheumatica?
The cause is unknown. PMR may occur alone, or with or before giant cell arteritis (also called temporal arteritis), which is inflammation of blood vessels (usually in the head).
Who is at highest risk?
Polymyalgia rheumatica is a disorder that almost always occurs in people over 50 years old.
Diagnosis
Lab tests cannot diagnose polymyalgia rheumatica. However, most patients with this condition have an elevated erythrocyte sedimentation rate (ESR), a blood test that can show certain kinds of inflammation.
Other test results for this condition (as well as for giant cell arteritis) include:
- Abnormal proteins in the blood
- Abnormal white blood cells
- Reduced hemoglobin and hematocrit
- Signs of anemia
These tests may also be used to monitor patients' progress.
When to seek urgent medical care?
Call for an appointment with your health care provider if you have persistent weakness or stiffness of the shoulder and neck area, especially if you also have symptoms of general illness, such as fever or headache.
Treatment options
Although there is no cure for polymyalgia rheumatica, treatment can help prevent patients from becoming disabled.
Low doses of corticosteroids (such as prednisone) can relieve polymyalgia rheumatica within a day or two. The dose can then be slowly reduced to a very low level, but the treatment will need to continue for a long time -- around 2 - 6 years. Physical therapy helps in building the strength and reducing the stiffness.
Corticosteroids cause a variety of side effects that must be carefully monitored and managed.
Where to find medical care for Polymyalgia rheumatica?
Directions to Hospitals Treating Polymyalgia rheumatica
What to expect (Outlook/Prognosis)?
Polymyalgia rheumatica usually goes away by itself after 2 - 6 years. After this time, treatment can be stopped.
Possible complications
Polymyalgia rheumatica can cause serious disabilities if untreated.
Prevention of Polymyalgia rheumatica
There is no known prevention.
Sources
http://www.nlm.nih.gov/medlineplus/ency/article/000415.htm Template:WH Template:WS